Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Vijay rakesh - What They Never Told You

Following the Post-IPO Quiet Period Expiration, Here’s Why Cerebras Stock Is Moving Higher

With the post-IPO quiet period behind it, Wall Street is finally weighing in on Cerebras, and a wave of bullish analyst calls is giving investors fresh reasons to pay attention to CRBS stock.

Barchart

The Under-the-Radar AI Semiconductor Play You Shouldn’t Ignore

Why STM is the hidden gem in this buzzing semiconductor market.

Barchart

Broadcom Just Landed Game-Changing AI Deals. Is AVGO a Buy Now?

These multi-year deals could cement Broadcom as one of the biggest winners of the AI infrastructure race.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Mizuho Just Slashed Its Price Target on Super Micro Stock by 25%

Wall Street is growing increasingly cautious on Super Micro as regulatory troubles cast a shadow over its AI-driven momentum.

Barchart

Qualcomm: Wall Street’s Patience Is Wearing Thin

Qualcomm’s first downgrade of 2026 has investors wondering whether this latest pullback is a warning or a buying opportunity.

MarketBeat

Broadcom Earns ‘Top Pick’ Status From Wall Street’s Biggest Banks

Analysts at big banks are bullish on Broadcom in 2026. At least three have named the stock a "top pick" for the new year.

MarketBeat

Wall Street’s Not Sure What to Think About Nvidia’s Deal for Groq, But Mizuho Says You Should Keep Buying NVDA Stock

Nvidia stock in focus as the chipmaker announces $20 billion Groq deal. Mizuho analyst explains why the transaction is largely bullish for NVDA shares.

Barchart

Read news from The Economist, FT, and more,
with one subscription

AMD Stock Is Up 78% in 2025. What to Expect for Shares in 2026... and Beyond

AMD stock had a blockbuster 2025 but Mizuho sees it climbing further next year. Here’s what could drive AMD shares higher in 2026.

Barchart

Tesla To Rally Around 4%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mixed, with the Dow Jones index falling over 100 points on Tuesday.

Benzinga

Why Mizuho Thinks AMD Stock Can Knock Out $135 in 2025

AMD stock has already soared in recent weeks, but a senior Mizuho analyst says AMD shares could extend gains further on the back of the company’s AI infrastructure deal with Humain.

Barchart

Middle East Deals Could Lift Super Micro Computer Stock. How Should You Play SMCI Here?

Supermicro stock has rallied sharply in recent sessions as investors cheer the AI server firm’s deal with DataVolt. But analysts suggest it’s as far as SMCI shares go in 2025.

Barchart

Stock Market Today: Markets Celebrate Trump's Tariff Détente

Consumer discretionary stocks led the 11 S&P 500 sector groups well into the green.

Kiplinger

Tesla Stock Gets Hit With Another Price Target Cut. Do Trump’s Tariffs Mean Doomsday for TSLA?

Mizuho analyst Vijay Rakesh lowered his price target on Tesla stock as it continues to tank amidst the broader selloff in tech stocks.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Why This Expert Says It’s Time to Worry About Tesla Stock

Shrinking European sales and heightened market pressures spark expert warnings over Tesla’s ability to maintain its leadership.

Kiplinger

Stock Market Today: The Dow Slides Into Its First 9-Day Losing Streak Since 1978

A Santa Claus rally is on hold as markets wait for more information about monetary policy.

Barchart

Up 89% in a Month, Is It Too Late to Buy This Surging Semiconductor Stock?

After a jaw-dropping recovery of 89% in just the past month, is it too late to grab a piece of Wolfspeed stock?

Barchart

Broadcom 2025 Forecast: Will This AI Semiconductor Stock Top $1 Trillion?

With demand for AI chips skyrocketing, chip giant Broadcom is tantalizingly close to the milestone of crossing the $1 trillion mark.

Get all your
news in one place.

100's of premium titles.
One news app.

Zenger

ON Semiconductor Surges On Upbeat Q2 Earnings, Analysts Boost Price Targets

Automotive and Industrial Growth Drive Strong Results, SiC Production Exceeds Expectations.

Zenger

Tesla Slumps Despite Earnings Beat, Rivian Bullish, Nikola Sells Hydrogen Project: EV Stock Roundup

Tesla underperforms as investors focus on Musk's comments; Rivian bullish, Nikola sells hydrogen project, Fisker targets Indian market.

Benzinga

Why These AMD Analysts Are Cutting Price Targets As Stock Rallies Off Q3 Earnings

Advanced Micro Devices, Inc. (NASDAQ: AMD) Tuesday reported downbeat third-quarter revenues and earnings.

Benzinga

Tesla And Other EV Makers From Benzinga's Most Accurate Analysts

The U.S. is reportedly in discussions to subject Elon Musk’s companies to national security reviews . Tesla Inc’s (NASDAQ: TSLA) CEO has also been locked in a battle over buying Twitter Inc. (NYSE: TWTR).

Benzinga

Why These 5 Tesla Analysts Have Mixed Views On Q3: 'We Were Prepared For An Earnings Miss'

Tesla Inc (NASDAQ: TSLA) reported record revenue, operating margins and free cash flow in the third quarter.

Benzinga

Mizuho Analyst Remains Bullish On The EV Sector; Finds Rivian Better Positioned

Mizuho analyst Vijay Rakesh reiterated his Buy ratings on Rivian Automotive, Inc (NASDAQ:RIVN) and the $65 price target. He saw RIVN as a pure play and a strong early mover in the EV market, focusing on the higher-growth SUV and light truck market and a robust commercial vehicle roadmap beginning with Amazon.Com, Inc. (NASDAQ:AMZN). Rivian is…

Benzinga

Micron Technology Earnings Were 'Materially Worse' Than Expected: 6 Analysts Comment

Micron Technology Inc. (NASDAQ: MU) released fiscal fourth-quarter results after the closing bell on Thursday. The Boise, Idaho-based company reported downbeat revenues of $6.64 billion and adjusted earnings of $1.45 per share, ahead of the consensus estimate.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.